definiens: means the respective periods of three ( 3 ) consecutive calendar months ending on March 31, June 30, September 30 and December 31 1.6 with respect to Acuitas, shall be deemed to have occurred if during the Term ( i ) any person or entity is or becomes the, directly or indirectly, of shares of capital stock or other interests ( including partnership interests ) of Acuitas then outstanding and normally entitled ( without regard to the occurrence of an y contingency ) to vote in the election of the directors, managers or similar supervisory positions of Acuitas representing fifty percent ( 50 % ) or more of the total voting power of all outstanding classes of voting stock of Acuitas or has the power, directl y or indirectly, to elect a majority of the members of the Acuitas ’ board of directors, or similar governing body ; or ( ii ) Acuitas enters into a merger, consolidation or similar transaction with another person or entity ; or ( iii ) Acuitas sells or transfers to any Third Party, in one ( 1 ) or more related transactions, properties or assets representing all or substantially all of Acuitas ’ consolidated total assets to which this Agreement relates ; or ( iv ) the holders of capital stock of Acuitas approve a plan o r proposal for the liquidation or dissolution of Acuitas . ” 1.7 means a Licensed Product that includes at least one additional active ingredient other than a Licensed Product . Drug delivery vehicles, adjuvants, and excipie nts shall not be deemed to be, except in the case where such delivery vehicle, adjuvant, or excipient is recognized as an active ingredient in accordance with 21 C.F.R. 210.3(b)(7 ) or equivalent Laws in other jurisdictions, provided however, should lipid nanoparticles comprised in a Licensed Product be characterized as at any time during the Term, such lipid nanoparticles will not be considered an for the purposes of this definition